← Insider buys

Robert Joseph Ball has bought SI on 3 days since Sep 2025

CEO and Executive Chair at Shoulder Innovations, Inc.

SEC CIK 0002070664 · Filings on SEC.gov ↗

$263KBought
$188KSold
Mar 17Last buy

Robert Joseph Ball's record

3 months after each buy, from the first price a copier could get.

+4.8%Average
+0.8 ptsVs S&P 500
2 of 3Higher

3 buys since 2025 with 3 months of prices.

Every filing

4 filings since Sep 2025, newest first

About Robert Joseph Ball

Robert Joseph Ball is the Executive Chairman and CEO of Shoulder Innovations, Inc. (NYSE: SI), a specialized orthopedic device company focused on shoulder replacement technology( With over two decades of experience in medical device development, Ball has established himself as a key innovator in orthopedics, holding more than 30 issued or pending patents( He earned both his Bachelor's and Master's degrees in Mechanical Engineering from Kettering University, with specialized focus on automotive engineering and mechanical design( His career spans roles at major medical device companies including Johnson & Johnson's DePuy division, where he gained foundational expertise in product development and regulatory processes(

Ball's most significant professional achievement came during his tenure at Tornier (now Wright Medical), where he served as Global Vice President of Research and Development for approximately eight years and drove substantial organic revenue growth from $40-50 million to $300 million( In 2013, he co-founded Genesis Innovation Group, an early-stage advisory firm for medical device technology that operates multiple subsidiaries including Genesis Software Innovations and Revelation Medical Devices( At Shoulder Innovations, Ball has led the company's development and commercialization of proprietary InSet® glenoid fixation technology, addressing critical challenges in shoulder arthroplasty and establishing the company's position as a market leader( Under his leadership, Shoulder Innovations successfully completed its initial public offering on the New York Stock Exchange in 2026(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.